M2613
M2613 is a nonsteroidal estrogen derived from triphenylbromoethylene which was studied in the treatment of breast cancer in females in the 1940s but was never marketed.
Clinical data | |
---|---|
Other names | M-2613; Methoxyethoxy-triphenylbromoethylene |
Drug class | Nonsteroidal estrogen |
Identifiers | |
| |
CAS Number | |
Chemical and physical data | |
Formula | C23H21BrO2 |
Molar mass | 409.323 g·mol−1 |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.